PLM-70011-08690 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-18
Registered in v-safe
2021-01-18
Dose 1 — Pfizer-BioNTech
2021-01-18
Survey response — day 0, dose 1
MedDRA: Oropharyngeal pain — Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work

Free text: Slight sore throat

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-18
Report sent to call center — day 0, dose 1
Be unable to work

1 call case(s)
2021-01-19
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work

Adult check-in
2021-01-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-07-19
Survey response — 6 months, dose 1
MedDRA: Immune system disorder — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Mast cell disorder

MedDRA releases: 2024-11 · check-in free text available
2021-07-19
Report sent to call center — 6 months, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-21
Call 1 — Left Voicemail
2022-01-22
Survey response — 12 months, dose 1
MedDRA: Chest pain, Dizziness, Dyspnoea, Exercise tolerance decreased — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Chest pain, inability to exercise, dizziness and shortness of breath. All started after 2nd shot in Feb 2021

MedDRA releases: 2024-11 · check-in free text available
2022-01-22
Report sent to call center — 12 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-01-24
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-18	Pfizer-BioNTech

Call center

3 call center cases

2 unsuccessful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 2 — day 0, dose 1

2021-01-18

Systemic reaction (other): Slight sore throat

Release 9 — 6 months, dose 1

2021-07-19

Symptoms: Mast cell disorder

Release 11 — 12 months, dose 1

2022-01-22

Symptoms: Chest pain, inability to exercise, dizziness and shortness of breath. All started after 2nd shot in Feb 2021

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Chest pain	·	·	✓
SD	Dizziness	·	·	✓
SD	Dyspnoea	·	·	✓
SD	Exercise tolerance decreased	·	·	✓
SD	Immune system disorder	·	·	✓
SRO	Oropharyngeal pain	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release